The U.S. Food and Drug Administration (FDA) has reported that over 500,000 bottles of blood pressure medication have already been recalled after a cancer-causing impurity was noticed in them.
On the 7th of October, a pharmaceutical company, Teva Pharmaceuticals USA, that is situated in Parsippany, part of New Jersey, has decided of its own will to recall some of its prazosin hydrochloride capsules.
The Food and Drug Administration in the United States later classified the recall process on October 24 as a Class II risk.
Prazosin, which got the approval to treat high blood pressure, is also widely known to have been prescribed off-label to manage post-traumatic stress disorder-related symptoms such as sleep issues and nightmares.
The FDA had already stated that risks that fall under Class II recalls include products that are very likely to cause temporary or medically reversible health effects, which will likely not cause terrible harm.
The medications that are affected may have nitrosamine impurities, specifically “N-nitroso Prazosin impurity C,” which has been said to speed up cancer risk in them.
The U.S. Food and Drug Administration (FDA) has also mentioned that it advises patients to reach out to consult medical experts before they change or stop using their prescribed medication.
Let's Hear Your Opinion About Us. Rate Us On:
